Clinical Trials Browser

Phase 1 × Unknown × Peptides × Clear all

NCT04072900 2020-04-28

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Phase 1 Unknown

Melanoma, Neoplasm Metastasis